Evidence map›Paper›PMID 24123648›Full record

ArticleDepression and anxiety2013

Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women.

Erika J Wolf, Karen S Mitchell, Mark W Logue, Clinton T Baldwin, Annemarie F Reardon, Donald E Humphries, Mark W Miller

Open access · greenAbstract read
In one paragraph

Article in Depression and anxiety, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Biomarkers of stress resilience: A review.Neuroscience applied · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. TheFrontiers in psychiatry · 2021
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Erika J WolfNational Center for PTSD, VA Boston Healthcare System, Boston, Massachusetts; Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts.
Karen S Mitchell
Mark W Logue
Clinton T Baldwin
Annemarie F Reardon
Donald E Humphries
Mark W Miller
Boston University · USVA Boston Healthcare System · USCenter for Human Genetics · USNational Center for PTSD · US

Funding

The Genetics of Negative Conflict BehaviorR01MH079806 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MILLER, MARK W · 2007 to 2011
$1.5M
Gene-Environment Interplay in the Comorbidity of PTSD and Disordered EatingK01MH093750 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MITCHELL, KAREN SUZANNE · 2012 to 2015
$703k
Analysis of RORA and other candidate genes in PTSDI01BX002150 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MILLER, MARK W · 2013 to 2015
–
The Structure of PTSD ComorbidityI01CX000431 · VA · VA BOSTON HEALTH CARE SYSTEM · PI MILLER, MARK W · 2011 to 2014
–
BLRD VA I01 BX002150CSRD VA CDA-2-067-10SCSRD VA I01 CX000431NIMH NIH HHS K01 MH093750NIMH NIH HHS K01MH093750NIMH NIH HHS R01 MH079806
6 · The paper itself

Abstract

backgroundThe corticotropin releasing hormone (CRH) system has been implicated in a variety of anxiety and mood-based symptoms and disorders. CRH receptor-2 (CRHR-2) plays a role in attenuating biological responses to stressful life events and trauma, making the CRHR-2 gene a strong candidate to study in relationship to PTSD.

methodsThe sample was 491 trauma-exposed white non-Hispanic veterans and their cohabitating intimate partners assessed via structured interview for lifetime DSM-IV PTSD; just over 60% met criteria for the disorder. Thirty-one single nucleotide polymorphisms (SNPs) in and near CRHR-2, obtained from an array of 2.5 million markers, were tested for association with PTSD diagnosis and symptom severity in the whole sample and in men and women separately.

resultsTen SNPs showed nominally significant evidence of association with PTSD in the full sample and two SNPs (rs8192496 and rs2190242) were significant after permutation-based multiple testing correction (uncorrected ps = .0004 and .0005, odds ratios = .60 and .58, respectively). Analyses stratified by sex revealed that the effect was specific to women, who comprised 35% of the sample (uncorrected ps = .0003 and .0002, odds ratios = .41 and .35, respectively). Two additional SNPs (rs2267715 and rs2284218) also showed significant association with PTSD in women (both uncorrected ps = .001, both odds ratios = .48).

conclusionsResults suggest that CRHR-2 variants may affect risk for PTSD in women by attenuating the stress response and reducing symptoms of the disorder.

Indexed as

AdultAgedFemaleGenetic Predisposition to DiseaseHumansMaleMiddle AgedPolymorphism, Single NucleotideReceptors, Corticotropin-Releasing HormoneSeverity of Illness IndexSex FactorsSpousesStress Disorders, Post-TraumaticVeteransWhite PeopleYoung AdultCRF receptor type 2Receptors, Corticotropin-Releasing Hormonelatent variablePTSDrs2284218rs8192496single nucleotide polymorphismsveteranswomen

Identifiers

PMID24123648
PMCPMC3855198
OpenAlexW2149971432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.